Werewolf Therapeutics Insider Sell‑Off: 43k Shares at Market Price—What It Means for Investors
Werewolf Therapeutics insider sale: Director EVNIN LUKE sells 43k+ shares at $0.55, a planned 10b5‑1 exit that may signal confidence issues amid a 49% stock drop.
3 minutes to read